Clinical Trials Browser

Phase 3 × Nasopharyngeal Carcinoma × Cetuximab × Clear all

NCT02633176 2015-12-17

Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma

Phase 3 Unknown

Nasopharyngeal Carcinoma